0.1M Tris, 0.1M Glycine, 10% Glycerol (pH7). 0.01% Thimerosal was added as a preservative.
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
0.3mg/ml(Please refer to the vial label for the specific concentration.)
Carrier-protein conjugated synthetic peptide encompassing a sequence within the C-terminus region of human PDE4D. The exact sequence is proprietary.
Purified by antigen-affinity chromatography.
For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
DKFZp686M11213 antibody, DPDE3 antibody, FLJ97311 antibody, HSPDE4D antibody, PDE4DN2 antibody, STRK1 antibody, PDE4D antibody, "phosphodiesterase 4D, cAMP-specific (phosphodiesterase E3 dunce homolog, Drosophila) antibody", cAMP-specific phosphodiesterase PDE4D6 antibody, "cAMP-specific 3',5'-cyclic phosphodiesterase 4D antibody", dunce-like phosphodiesterase E3 antibody, "phosphodiesterase 4D, cAMP-specific antibody"
Cytoplasm (By similarity) , Membrane (By similarity) , Cytoplasm , cytoskeleton (By similarity) , Centrosome (By similarity)
The PDE4D gene is complex and has at least 9 different isoforms that encode functional proteins. These proteins degrade the second messenger cAMP, which is a key signal transduction molecule in multiple cell types, including vascular cells (Dominiczak and McBride, 2003 [PubMed 14517535]).[supplied by OMIM]